Oncology How automating flow cytometry is revolutionising cancer diag... As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise.
Oncology ASCO 2024: Emphasising the art and science behind enhanced c... The term “practice-changing” is often used when scientific advances promise to shift traditional treatment paradigms.
Oncology Sponsored Clinical decision-making insights for haem/oncs Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several decision-making challenges for healthcare professionals.
Partner Content Partner Content When science and biology combine – the outlook for ADCs in c... Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
